 | R1D | Name: | 5-hydroxy-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-oxo-2-[2-(trifluoromethyl)phenyl]-1,6-dihydropyrimidine-4-carboxamide | Formula: | C21 H18 F3 N3 O5 | SMILES: | COc1c(ccc(c1)CCNC(C=3N=C(c2ccccc2C(F)(F)F)NC(C=3O)=O)=O)O | InChi: | InChI=1S/C21H18F3N3O5/c1-32-15-10-11(6-7-14(15)28)8-9-25-19(30)16-17(29)20(31)27-18(26-16)12-4-2-3-5-13(12)21(22,23)24/h2-7,10,28-29H,8-9H2,1H3,(H,25,30)(H,26,27,31) | Definition date: | 2020-01-23 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | 5-hydroxy-N-[2-(4-hydroxy-3-methoxyphenyl)ethyl]-6-oxo-2-[2-(trifluoromethyl)phenyl]-1,6-dihydropyrimidine-4-carboxamide |
|
 | R7J | Name: | [5-(3-fluorophenyl)-1-benzofuran-3-yl]acetic acid | Formula: | C16 H11 F O3 | SMILES: | c2cc1c(c(CC(O)=O)co1)cc2c3cccc(c3)F | InChi: | InChI=1S/C16H11FO3/c17-13-3-1-2-10(6-13)11-4-5-15-14(7-11)12(9-20-15)8-16(18)19/h1-7,9H,8H2,(H,18,19) | Definition date: | 2020-02-06 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | [5-(3-fluorophenyl)-1-benzofuran-3-yl]acetic acid |
|
 | R7P | Name: | 2-({4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-2-methoxyphenyl}amino)-9-methyl-5,7-dihydro-6H-pyrimido[5,4-d][1,3]benzodiazepin-6-one | Formula: | C25 H29 N7 O2 | SMILES: | COc1cc(ccc1Nc4ncc3NC(=O)Nc2cc(C)ccc2c3n4)N5CC(C)NC(C)C5 | InChi: | InChI=1S/C25H29N7O2/c1-14-5-7-18-20(9-14)29-25(33)30-21-11-26-24(31-23(18)21)28-19-8-6-17(10-22(19)34-4)32-12-15(2)27-16(3)13-32/h5-11,15-16,27H,12-13H2,1-4H3,(H,26,28,31)(H2,29,30,33)/t15-,16+ | Definition date: | 2020-02-06 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | 2-({4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-2-methoxyphenyl}amino)-9-methyl-5,7-dihydro-6H-pyrimido[5,4-d][1,3]benzodiazepin-6-one |
|
 | RJB | Name: | 2-[2-(1,3-benzothiazol-2-ylmethylcarbamoyl)-1,3-dihydroinden-2-yl]ethanoic acid | Formula: | C20 H18 N2 O3 S | SMILES: | OC(=O)CC1(Cc2ccccc2C1)C(=O)NCc3sc4ccccc4n3 | InChi: | InChI=1S/C20H18N2O3S/c23-18(24)11-20(9-13-5-1-2-6-14(13)10-20)19(25)21-12-17-22-15-7-3-4-8-16(15)26-17/h1-8H,9-12H2,(H,21,25)(H,23,24) | Definition date: | 2020-09-30 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | 2-[2-(1,3-benzothiazol-2-ylmethylcarbamoyl)-1,3-dihydroinden-2-yl]ethanoic acid |
|
 | SR5 | Name: | (2~{S})-2-[[1-(7-chloranylquinolin-4-yl)-5-(2,6-dimethoxyphenyl)pyrazol-3-yl]carbonylamino]-4-methyl-pentanoic acid | Formula: | C27 H27 Cl N4 O5 | SMILES: | COc1cccc(OC)c1c2cc(nn2c3ccnc4cc(Cl)ccc34)C(=O)N[CH](CC(C)C)C(O)=O | InChi: | InChI=1S/C27H27ClN4O5/c1-15(2)12-20(27(34)35)30-26(33)19-14-22(25-23(36-3)6-5-7-24(25)37-4)32(31-19)21-10-11-29-18-13-16(28)8-9-17(18)21/h5-11,13-15,20H,12H2,1-4H3,(H,30,33)(H,34,35)/t20-/m0/s1 | Definition date: | 2020-06-08 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | (2~{S})-2-[[1-(7-chloranylquinolin-4-yl)-5-(2,6-dimethoxyphenyl)pyrazol-3-yl]carbonylamino]-4-methyl-pentanoic acid |
|
 | SR9 | Name: | (2~{S})-4-methyl-2-[(1-quinolin-8-ylsulfonylindol-3-yl)carbonylamino]pentanoic acid | Formula: | C24 H23 N3 O5 S | SMILES: | CC(C)C[CH](NC(=O)c1cn(c2ccccc12)[S](=O)(=O)c3cccc4cccnc34)C(O)=O | InChi: | InChI=1S/C24H23N3O5S/c1-15(2)13-19(24(29)30)26-23(28)18-14-27(20-10-4-3-9-17(18)20)33(31,32)21-11-5-7-16-8-6-12-25-22(16)21/h3-12,14-15,19H,13H2,1-2H3,(H,26,28)(H,29,30)/t19-/m0/s1 | Definition date: | 2020-06-04 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | (2~{S})-4-methyl-2-[(1-quinolin-8-ylsulfonylindol-3-yl)carbonylamino]pentanoic acid |
|
 | GE0 | Name: | [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(3R)-2,2-dimethyl-3-oxidanyl-4-oxidanylidene-4-[[3-oxidanylidene-3-[2-(2-oxidanylideneheptadecylsulfanyl)ethylamino]propyl]amino]butyl] hydrogen phosphate | Formula: | C38 H68 N7 O17 P3 S | SMILES: | CCCCCCCCCCCCCCCC(=O)CSCCNC(=O)CCNC(=O)[CH](O)C(C)(C)CO[P](O)(=O)O[P](O)(=O)OC[CH]1O[CH]([CH](O)[CH]1O[P](O)(O)=O)n2cnc3c(N)ncnc23 | InChi: | InChI=1S/C38H68N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-27(46)23-66-21-20-40-29(47)18-19-41-36(50)33(49)38(2,3)24-59-65(56,57)62-64(54,55)58-22-28-32(61-63(51,52)53)31(48)37(60-28)45-26-44-30-34(39)42-25-43-35(30)45/h25-26,28,31-33,37,48-49H,4-24H2,1-3H3,(H,40,47)(H,41,50)(H,54,55)(H,56,57)(H2,39,42,43)(H2,51,52,53)/t28-,31-,32-,33+,37-/m1/s1 | Definition date: | 2020-08-20 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(3~{R})-2,2-dimethyl-3-oxidanyl-4-oxidanylidene-4-[[3-oxidanylidene-3-[2-(2-oxidanylideneheptadecylsulfanyl)ethylamino]propyl]amino]butyl] hydrogen phosphate |
|
 | H1X | Name: | 2-[(5-tert-butyl-2-methyl-phenyl)sulfonylamino]benzoic acid | Formula: | C18 H21 N O4 S | SMILES: | Cc1ccc(cc1[S](=O)(=O)Nc2ccccc2C(O)=O)C(C)(C)C | InChi: | InChI=1S/C18H21NO4S/c1-12-9-10-13(18(2,3)4)11-16(12)24(22,23)19-15-8-6-5-7-14(15)17(20)21/h5-11,19H,1-4H3,(H,20,21) | Definition date: | 2020-10-26 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | 2-[(5-~{tert}-butyl-2-methyl-phenyl)sulfonylamino]benzoic acid |
|
 | H29 | Name: | 6-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)pyridin-3-amine | Formula: | C12 H13 N3 S | SMILES: | Nc1ccc(nc1)N2CCc3sccc3C2 | InChi: | InChI=1S/C12H13N3S/c13-10-1-2-12(14-7-10)15-5-3-11-9(8-15)4-6-16-11/h1-2,4,6-7H,3,5,8,13H2 | Definition date: | 2020-10-26 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | 6-(6,7-dihydro-4~{H}-thieno[3,2-c]pyridin-5-yl)pyridin-3-amine |
|
 | H2C | Name: | 1-[(4-fluorophenyl)methyl]-2,2-bis(oxidanylidene)thieno[3,2-c][1,2]thiazin-4-one | Formula: | C13 H10 F N O3 S2 | SMILES: | Fc1ccc(CN2c3ccsc3C(=O)C[S]2(=O)=O)cc1 | InChi: | InChI=1S/C13H10FNO3S2/c14-10-3-1-9(2-4-10)7-15-11-5-6-19-13(11)12(16)8-20(15,17)18/h1-6H,7-8H2 | Definition date: | 2020-10-26 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | 1-[(4-fluorophenyl)methyl]-2,2-bis(oxidanylidene)thieno[3,2-c][1,2]thiazin-4-one |
|
 | H2X | Name: | 4-bromanyl-2-[[2-[(E)-1-(3-methoxyphenyl)ethylideneamino]propan-2-ylamino]methyl]phenol | Formula: | C19 H23 Br N2 O2 | SMILES: | COc1cccc(c1)C(C)=NC(C)(C)NCc2cc(Br)ccc2O | InChi: | InChI=1S/C19H23BrN2O2/c1-13(14-6-5-7-17(11-14)24-4)22-19(2,3)21-12-15-10-16(20)8-9-18(15)23/h5-11,21,23H,12H2,1-4H3/b22-13+ | Definition date: | 2020-10-28 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | 4-bromanyl-2-[[2-[(~{E})-1-(3-methoxyphenyl)ethylideneamino]propan-2-ylamino]methyl]phenol |
|
 | H30 | Name: | 5'-methoxy-6'-(1-methyl-2,3,4,7-tetrahydroazepin-5-yl)spiro[cyclobutane-1,3'-indole]-2'-amine | Formula: | C19 H25 N3 O | SMILES: | COc1cc2c(cc1C3=CCN(C)CCC3)N=C(N)C24CCC4 | InChi: | InChI=1S/C19H25N3O/c1-22-9-3-5-13(6-10-22)14-11-16-15(12-17(14)23-2)19(7-4-8-19)18(20)21-16/h6,11-12H,3-5,7-10H2,1-2H3,(H2,20,21) | Definition date: | 2020-10-29 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | 5'-methoxy-6'-(1-methyl-2,3,4,7-tetrahydroazepin-5-yl)spiro[cyclobutane-1,3'-indole]-2'-amine |
|
 | KKL | Name: | 4-amino-N-[5-(4-ethynylphenyl)-1,3,4-oxadiazol-2-yl]benzamide | Formula: | C17 H12 N4 O2 | SMILES: | c1cc(ccc1C(Nc3nnc(c2ccc(cc2)C#C)o3)=O)N | InChi: | InChI=1S/C17H12N4O2/c1-2-11-3-5-13(6-4-11)16-20-21-17(23-16)19-15(22)12-7-9-14(18)10-8-12/h1,3-10H,18H2,(H,19,21,22) | Definition date: | 2019-04-19 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | 4-amino-N-[5-(4-ethynylphenyl)-1,3,4-oxadiazol-2-yl]benzamide |
|
 | N7X | Name: | 5'-O-[(R)-hydroxy(sulfanylidene)-lambda~5~-phosphanyl]-2'-O-(2-methoxyethyl)-5-methylcytidine | Formula: | C13 H22 N3 O8 P S | SMILES: | C(COC)OC1C(OC(C1O)COP(O)(O)=S)N2C(N=C(C(C)=C2)N)=O | InChi: | InChI=1S/C13H22N3O8PS/c1-7-5-16(13(18)15-11(7)14)12-10(22-4-3-21-2)9(17)8(24-12)6-23-25(19,20)26/h5,8-10,12,17H,3-4,6H2,1-2H3,(H2,14,15,18)(H2,19,20,26)/t8-,9-,10-,12-/m1/s1 | Definition date: | 2020-02-11 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | 2'-O-(2-methoxyethyl)-5-methyl-5'-O-thiophosphonocytidine |
|
 | EWO | Name: | (4R)-4-(4-fluorophenyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine | Formula: | C12 H12 F N3 | SMILES: | Fc1ccc(cc1)[CH]2NCCc3[nH]cnc23 | InChi: | InChI=1S/C12H12FN3/c13-9-3-1-8(2-4-9)11-12-10(5-6-14-11)15-7-16-12/h1-4,7,11,14H,5-6H2,(H,15,16)/t11-/m1/s1 | Definition date: | 2020-02-12 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | (4~{R})-4-(4-fluorophenyl)-4,5,6,7-tetrahydro-1~{H}-imidazo[4,5-c]pyridine |
|
 | DC1 | Name: | 5,5-DIMETHYLCYCLOHEXANE-1,3-DIONE | Formula: | C8 H12 O2 | SMILES: | O=C1CC(=O)CC(C)(C)C1 | InChi: | InChI=1S/C8H12O2/c1-8(2)4-6(9)3-7(10)5-8/h3-5H2,1-2H3 | Synonyms: | 2,2 DIMETHYL,1,6 CYCLOHEXA DIONE | Definition date: | 2004-09-14 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | 5,5-dimethylcyclohexane-1,3-dione |
|
 | P4N | Name: | 6-[[4-[(3-methylsulfonylphenyl)methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-3,4-dihydro-1~{H}-quinolin-2-one | Formula: | C22 H20 F3 N5 O3 S | SMILES: | C[S](=O)(=O)c1cccc(CNc2nc(Nc3ccc4NC(=O)CCc4c3)ncc2C(F)(F)F)c1 | InChi: | InChI=1S/C22H20F3N5O3S/c1-34(32,33)16-4-2-3-13(9-16)11-26-20-17(22(23,24)25)12-27-21(30-20)28-15-6-7-18-14(10-15)5-8-19(31)29-18/h2-4,6-7,9-10,12H,5,8,11H2,1H3,(H,29,31)(H2,26,27,28,30) | Definition date: | 2020-04-15 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | 6-[[4-[(3-methylsulfonylphenyl)methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-3,4-dihydro-1~{H}-quinolin-2-one |
|
 | P7N | Name: | ~{N}-methyl-~{N}-[3-[[[2-[(2-oxidanylidene-3,4-dihydro-1~{H}-quinolin-6-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]methyl]pyridin-2-yl]methanesulfonamide | Formula: | C22 H22 F3 N7 O3 S | SMILES: | CN(c1ncccc1CNc2nc(Nc3ccc4NC(=O)CCc4c3)ncc2C(F)(F)F)[S](C)(=O)=O | InChi: | InChI=1S/C22H22F3N7O3S/c1-32(36(2,34)35)20-14(4-3-9-26-20)11-27-19-16(22(23,24)25)12-28-21(31-19)29-15-6-7-17-13(10-15)5-8-18(33)30-17/h3-4,6-7,9-10,12H,5,8,11H2,1-2H3,(H,30,33)(H2,27,28,29,31) | Definition date: | 2020-04-16 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | ~{N}-methyl-~{N}-[3-[[[2-[(2-oxidanylidene-3,4-dihydro-1~{H}-quinolin-6-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]methyl]pyridin-2-yl]methanesulfonamide |
|
 | P9K | Name: | N-Methyl-N-(2-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-phenyl)-methanesulfonamide | Formula: | C22 H19 F3 N6 O3 S | SMILES: | CN(c1ccccc1C=Nc2nc(Nc3ccc4NC(=O)Cc4c3)ncc2C(F)(F)F)[S](C)(=O)=O | InChi: | InChI=1S/C22H19F3N6O3S/c1-31(35(2,33)34)18-6-4-3-5-13(18)11-26-20-16(22(23,24)25)12-27-21(30-20)28-15-7-8-17-14(9-15)10-19(32)29-17/h3-9,11-12H,10H2,1-2H3,(H,29,32)(H,27,28,30)/b26-11+ | Definition date: | 2020-04-20 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | ~{N}-methyl-~{N}-[2-[(~{E})-[2-[(2-oxidanylidene-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]iminomethyl]phenyl]methanesulfonamide |
|
 | PKE | Name: | ~{N}-methyl-~{N}-[3-[[[2-[(2-oxidanylidene-1,3-dihydroindol-5-yl)amino]pyrimidin-4-yl]amino]methyl]pyridin-2-yl]methanesulfonamide | Formula: | C20 H21 N7 O3 S | SMILES: | CN(c1ncccc1CNc2ccnc(Nc3ccc4NC(=O)Cc4c3)n2)[S](C)(=O)=O | InChi: | InChI=1S/C20H21N7O3S/c1-27(31(2,29)30)19-13(4-3-8-21-19)12-23-17-7-9-22-20(26-17)24-15-5-6-16-14(10-15)11-18(28)25-16/h3-10H,11-12H2,1-2H3,(H,25,28)(H2,22,23,24,26) | Definition date: | 2020-04-24 | Last modified: | 2021-02-05 | Release date: | 2021-02-10 | Identifier: | ~{N}-methyl-~{N}-[3-[[[2-[(2-oxidanylidene-1,3-dihydroindol-5-yl)amino]pyrimidin-4-yl]amino]methyl]pyridin-2-yl]methanesulfonamide |
|
 | 16M | Name: | (ethylsulfanyl)benzene | Formula: | C8 H10 S | SMILES: | ethyl phenyl sulfide | InChi: | InChI=1S/C8H10S/c1-2-9-8-6-4-3-5-7-8/h3-7H,2H2,1H3 | Synonyms: | ethy lphenyl sulfide | Definition date: | 2012-10-22 | Last modified: | 2021-02-02 | Release date: | 2013-10-30 | Identifier: | (ethylsulfanyl)benzene |
|
 | VE4 | Name: | 4-[(E)-({1-carboxy-2-[(3R)-3-hydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl]ethan-1-id-1-yl}iminio)methyl]-2-methyl-5-[(phosphonooxy)methyl]pyridin-1-ium-3-olate | Formula: | C19 H20 N3 O9 P | SMILES: | C(c1c[nH+]c(c(c1[C@H]=[NH+][C-](CC3(O)c2ccccc2NC3=O)C(O)=O)[O-])C)OP(O)(=O)O | InChi: | InChI=1S/C19H20N3O9P/c1-10-16(23)12(11(7-20-10)9-31-32(28,29)30)8-21-15(17(24)25)6-19(27)13-4-2-3-5-14(13)22-18(19)26/h2-5,7-8,21,23,27H,6,9H2,1H3,(H,22,26)(H,24,25)(H2,28,29,30)/b21-8+/t19-/m1/s1 | Definition date: | 2020-07-31 | Last modified: | 2021-01-29 | Release date: | 2021-02-03 | Identifier: | 4-[(E)-({1-carboxy-2-[(3R)-3-hydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl]ethan-1-id-1-yl}iminio)methyl]-2-methyl-5-[(phosphonooxy)methyl]pyridin-1-ium-3-olate |
|
 | XWS | Name: | (2R,4R)-1-phenylhexahydropyrimidine-2,4-diol | Formula: | C10 H14 N2 O2 | SMILES: | N1(CCC(NC1O)O)c2ccccc2 | InChi: | InChI=1S/C10H14N2O2/c13-9-6-7-12(10(14)11-9)8-4-2-1-3-5-8/h1-5,9-11,13-14H,6-7H2/t9-,10-/m1/s1 | Definition date: | 2021-01-18 | Last modified: | 2021-01-29 | Release date: | 2021-02-03 | Identifier: | (2R,4R)-1-phenylhexahydropyrimidine-2,4-diol |
|
 | X51 | Name: | 1-[(4-aminobutyl)amino]ethane-1,1-diol | Formula: | C6 H16 N2 O2 | SMILES: | CC(O)(NCCCCN)O | InChi: | InChI=1S/C6H16N2O2/c1-6(9,10)8-5-3-2-4-7/h8-10H,2-5,7H2,1H3 | Definition date: | 2020-11-30 | Last modified: | 2021-01-29 | Release date: | 2021-02-03 | Identifier: | 1-[(4-aminobutyl)amino]ethane-1,1-diol |
|
 | X54 | Name: | 1-({4-[(3-aminopropyl)amino]butyl}amino)ethane-1,1-diol | Formula: | C9 H23 N3 O2 | SMILES: | C(CCNCCCCNC(C)(O)O)N | InChi: | InChI=1S/C9H23N3O2/c1-9(13,14)12-8-3-2-6-11-7-4-5-10/h11-14H,2-8,10H2,1H3 | Definition date: | 2020-11-30 | Last modified: | 2021-01-29 | Release date: | 2021-02-03 | Identifier: | 1-({4-[(3-aminopropyl)amino]butyl}amino)ethane-1,1-diol |
|